Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the end of the year as part of its effort to cut costs. In a statement on ...
Zacks Investment Research on MSN
ImmunityBio vs. Moderna: Which biotech has more upside potential?
Both ImmunityBio IBRX and Moderna MRNA are biotech firms that depend largely on the successful commercialization of a single ...
Massachusetts-based vaccine maker Moderna on Thursday announced plans to cut its workforce by approximately 10%. Moderna CEO Stéphane Bancel notified employees of the decision. His memo explained that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results